e-learning
resources
Virtual 2021
07.09.2021
Respiratory failure in COVID19 and beyond
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The dynamics of dyspnea in patients (pts) with pneumonia on the background of SARS-CoV2 infection
T. Pertseva (Dnipro, Ukraine), L. Konopkina (Dnipro, Ukraine), O. Myronenko (Dnipro, Ukraine), O. Shchudro (Dnipro, Ukraine)
Source:
Virtual Congress 2021 – Respiratory failure in COVID19 and beyond
Session:
Respiratory failure in COVID19 and beyond
Session type:
E-poster
Number:
3315
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Pertseva (Dnipro, Ukraine), L. Konopkina (Dnipro, Ukraine), O. Myronenko (Dnipro, Ukraine), O. Shchudro (Dnipro, Ukraine). The dynamics of dyspnea in patients (pts) with pneumonia on the background of SARS-CoV2 infection. 3315
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
The assessment of the metabolic dysfunction in patients (pts) after COVID-19 pneumonia
Source: Virtual Congress 2021 – Pulmonary rehabilitation in the COVID-19 era
Year: 2021
Definition of severity and the reasons for hospitalization (RH) in patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2005; 26: Suppl. 49, 641s
Year: 2005
How can I differentiate community-acquired pneumonia (CAP)+COPD patients from acute exacerbation of COPD (AECOPD) patients?
Source: International Congress 2015 – Differentiating COPD exacerbations from pneumonia in COPD patients
Year: 2015
Detection of liver function in patients with severe community-acquired pneumonia (CAP)
Source: Eur Respir J 2002; 20: Suppl. 38, 15s
Year: 2002
The estimation of respiratory muscles (RM) status by echodensitometry in male patients with acute exacerbation of COPD (AECOPD)
Source: Annual Congress 2010 - Interaction between respiratory and peripheral muscles
Year: 2010
The difference between surfactant protein D (SPD) and C-reactive protein (CRP) levels in patients (pts) with chronic obstructive pulmonary disease acute exacerbations (AE COPD) and community acquired pneumonia (CAP)
Source: International Congress 2014 – Clinical presentations
Year: 2014
An unbalanced inflammatory response on admission impacts clinical stability in hospitalized patients with community-acquired pneumonia (CAP)
Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia
Year: 2011
Mental disorders in patients (pts) with COVID-19 pneumonia:comparison with COPD exacerbation
Source: Virtual Congress 2021 – Long COVID - 19
Year: 2021
Enhanced neutrophil response in patients with chronic bronchitis and community-acquired pneumonia (CAP)
Source: Eur Respir J 2002; 20: Suppl. 38, 418s
Year: 2002
Acute phase proteins (APP) and serum iron in patients (pts) with simple community-acquired pneumonia (CAP)
Source: Eur Respir J 2006; 28: Suppl. 50, 805s
Year: 2006
Lower respiratory tract infection (LRTI): are there differences of microbial spectrum in stable phase (SP) of COPD and during acute exacerbation (AE)?
Source: Annual Congress 2009 - COPD: exacerbation and clinical problems
Year: 2009
Evaluation of Behcet‘s disease patients who admitted with pulmonary symptoms (analysis of 14 cases)
Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases
Year: 2007
The incidence of Q fever in hospitalized patients with community acquired pneumonia
Source: Annual Congress 2008 - Diagnostic tests in lower respiratory tract infections
Year: 2008
Differential therapy of acute respiratory failure (ARF) in chronic obstructive pulmonary disease (COPD) patients with predominance of emphysema (PE) and predominance of bronchitis (PB)
Source: Eur Respir J 2006; 28: Suppl. 50, 395s
Year: 2006
Influence of thiotriazolin on phlegm cytogram of patients with community acquired pneumonia (CAP)
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases
Year: 2008
Does the condition of chronic obstructive pumonary disease (COPD) have a prognostic benefit in patients with community-acquired pneumonia (CAP)?
Source: Eur Respir J 2003; 22: Suppl. 45, 338s
Year: 2003
An outbreak of pneumococcal-chlamydial pneumonia and acute respiratory disease (ARD) among trainees
Source: Eur Respir J 2001; 18: Suppl. 33, 464s
Year: 2001
Incidence of severe sepsis as a cause of clinical failure in patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2007; 30: Suppl. 51, 42s
Year: 2007
Is it connection between systemic inflammation and risk of thrombotic disorders (by Padua scale) in hospitalized patients with community-acquired pneumonia (CAP)?
Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection
Year: 2018
A delay in reaching time to clinical stability (tcs) for hospitalized patients with community-acquired pneumonia (CAP) is associated with failure within 30 days after hospital discharge
Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept